Decrypting the Crosstalk Mechanisms Between cGAS-STING and TBK1 Signaling Pathways in Cancer Immunotherapy: A Comprehensive Review
Journal of Cancer Biomoleculars and Therapeutics · 2025
DOI: 10.62382/jcbt.v2i1.42 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cancer Biomoleculars and Therapeutics, 2025. Verfasst von Sakuntala Gayen und 5 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
In the tumor microenvironment, the cytosolic DNA sensing, cyclic GMP-AMP synthase- stimulator of interferon genes (cGAS-STING) pathway is a crucial regulator of immune response. The cGAS of innate immunity recognizes cytoplasmic DNA by catalyzing cyclic GMP-AMP (cGAMP), which subsequently activates the STING pathway. STING activation leads to the phosphorylation of TANK-binding kinase 1 (TBK1) and recruitment of key transcription factor IRF3, notably to initiate the production of pro-inflammatory cytokines and Type I IFNs. This cascade enhances antigen presentation and primes cytotoxic T-cells, leading to the induction of anti-tumor immune response. Specific crosstalk mechanisms, such as TBK1-mediated negative feedback to limit excessive STING activation or its cooperation with NF-κB to balance immune responses, play pivotal roles in shaping tumor immunity. Harnessing this axis in cancer immunotherapy has emerged as a promising strategy, offering synergy with immune checkpoint blockade and CAR T-cells therapy. Fine-tuning activation of this pathway is crucial for balanced immune responses, making cGAS-STING/TBK1 signal transduction a major target for novel cancer therapies. This review elucidates the intricate crosstalk mechanisms of cGAS-STING and TBK1 signal transduction within tumor microenvironment. These may shed insight on cancer therapy options and their pivotal roles in modulating tumor immunity.
Zitieren
APA
Gayen, S., Parui, A., Arshad, A., Roy, N., Sarkar, A. N., & Roy, S. (2025). Decrypting the Crosstalk Mechanisms Between cGAS-STING and TBK1 Signaling Pathways in Cancer Immunotherapy: A Comprehensive Review. Journal of Cancer Biomoleculars and Therapeutics. https://doi.org/10.62382/jcbt.v2i1.42
Vancouver
Gayen S, Parui A, Arshad A, Roy N, Sarkar AN, Roy S. Decrypting the Crosstalk Mechanisms Between cGAS-STING and TBK1 Signaling Pathways in Cancer Immunotherapy: A Comprehensive Review. Journal of Cancer Biomoleculars and Therapeutics. 2025. doi:10.62382/jcbt.v2i1.42
BibTeX
@article{Gayen2025,
author = {Gayen, Sakuntala and Parui, Ankita and Arshad, Amima and Roy, Nipa and Sarkar, Asmita Nag and Roy, Souvik},
title = {Decrypting the Crosstalk Mechanisms Between cGAS-STING and TBK1 Signaling Pathways in Cancer Immunotherapy: A Comprehensive Review},
journal = {Journal of Cancer Biomoleculars and Therapeutics},
year = {2025},
doi = {10.62382/jcbt.v2i1.42}
}
EUVIMED